Rubitecan
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology
Reference8 articles.
1. A phase I clinical and pharmacological study of oral 9-nitrocamptothecin, a novel water-insoluble topoisomerase I inhibitor
2. A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer
3. A phase II study of 9-nitrocamptothecin in patients with advanced pancreatic adenocarcinoma
4. Phase II trial of 9-nitrocamptothecin (RFS 2000) for patients with metastatic cutaneous or uveal melanoma
5. A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Topoisomerase Inhibitors and Targeted Delivery in Cancer Therapy;Current Topics in Medicinal Chemistry;2019-06-20
2. Medicinal Plants Used in the Treatment of Human Immunodeficiency Virus;International Journal of Molecular Sciences;2018-05-14
3. Physicochemical Characterization, Solubilization, and Stabilization of 9-Nitrocamptothecin Using Pluronic Block Copolymers;Journal of Pharmaceutical Sciences;2013-10
4. Kinetic and thermodynamic analysis of 9-nitrocamptothecin hydrolysis at physiological pH in the presence and absence of human serum albumin;International Journal of Chemical Kinetics;2010-09-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3